BIOCON.NS Cash Flow
Biocon Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 8 years on file
(FY2018-19 to FY2025-26)
· fetched 2026-08-23 21:39
| Line item | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | N/A | N/A | ₹11.77 Bn | ₹18.52 Bn | ₹29.54 Bn | ₹40.61 Bn | ₹19.94 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | N/A | N/A | ₹-16.99 Bn | ₹-142.82 Bn | ₹-10.04 Bn | ₹-2.34 Bn | ₹-20.82 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | N/A | N/A | ₹2.42 Bn | ₹130.49 Bn | ₹-23.33 Bn | ₹-18.54 Bn | ₹-9.24 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | N/A | N/A | ₹0.03 Bn | ₹0.22 Bn | ₹0.03 Bn | ₹0.31 Bn | ₹1.99 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | N/A | N/A | ₹-2.77 Bn | ₹6.41 Bn | ₹-3.80 Bn | ₹20.04 Bn | ₹-8.12 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | N/A | N/A | ₹9.31 Bn | ₹6.54 Bn | ₹13.00 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from BIOCON.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).